Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Treatment of oncogene-addicted non-small cell lung cancer (NSCLC) has been changed by the advent of tyrosine kinase inhibitors (TKIs). Albeit great benefits are achieved with target therapies, resistance invariably occurs and recourse to alternative treatments is unavoidable. Immune chec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Autores principales: Guaitoli, Giorgia, Tiseo, Marcello, Di Maio, Massimo, Friboulet, Luc, Facchinetti, Francesco
Formato: Artigo
Lenguaje:Inglês
Publicado: AME Publishing Company 2021
Materias:
Original Article on Immunotherapy in Other Thoracic Malignancies and Uncommon Populations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264334/
https://ncbi.nlm.nih.gov/pubmed/34295687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-941
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares